NCT02126800|UnknownDMC
Rapid Medical Donation Programme for Breast Cancer
LEGACY
Loading search results
LEGACY
Sponsor study identifier
observational
60
1 country
1
Study Start
March 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Treatment of breast cancer has traditionally been based on the primary tumour's features in the breast. Only recently, when cancer returns at other sites, has there been an attempt to biopsy the metastatic disease and change treatments accordingly. A 'repeat biopsy' can be technically difficult, painful and, when possible, only represents a small sample of one of many metastases. Even when one deposit responds to a new treatment, a neighbouring one may continue to grow. There is an urgent need to characterise all deposits, particularly the lethal ones which progress despite all treatments. This study will enable the comprehensive analysis of the metastatic process and the evolution of the breast cancer through the course of its treatment. Patients who have consented during life to donate their tissues for molecular analysis will provide the means for such an analysis. Main aims:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2014
Date type not reportedThis date has not been verified as actual or estimated.
April 24, 2014
Actual (reported)April 30, 2014
Actual (reported)September 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The acquisition of tumour tissue from multiple metastatic sites.
Within 6 hours from the time of death.
Patients with proven metastatic breast cancer
Royal Marsden NHS Foundation Trust
London, SW3 6JJ, United Kingdom
Metastatic breast cancer
Peter A Barry, MB BS
Royal Marsden NHS Foundation Trust
First Submitted
April 24, 2014
First Posted
April 30, 2014
Study Start
March 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2017
Estimated (date passed)Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 30, 2014
Record last verified: 2014-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: